These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15168910

  • 1. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
    Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE.
    Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.
    Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D.
    Drug Alcohol Depend; 2004 Aug 16; 75(2):135-47. PubMed ID: 15276218
    [Abstract] [Full Text] [Related]

  • 5. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
    Zakzanis KK, Campbell Z, Jovanovski D.
    Hum Psychopharmacol; 2007 Oct 16; 22(7):427-35. PubMed ID: 17896346
    [Abstract] [Full Text] [Related]

  • 6. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.
    Drug Alcohol Depend; 2005 Jun 01; 78(3):317-23. PubMed ID: 15893163
    [Abstract] [Full Text] [Related]

  • 7. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan 01; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 8. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K.
    J Psychopharmacol; 1998 Jan 01; 12(1):79-83. PubMed ID: 9584971
    [Abstract] [Full Text] [Related]

  • 9. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
    Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.
    J Psychopharmacol; 2006 May 01; 20(3):389-99. PubMed ID: 16574713
    [Abstract] [Full Text] [Related]

  • 10. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
    Hanson KL, Luciana M.
    J Clin Exp Neuropsychol; 2010 Apr 01; 32(4):337-49. PubMed ID: 20397296
    [Abstract] [Full Text] [Related]

  • 11. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May 01; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
    Casco C, Forcella M, Beretta G, Grieco A, Campana G.
    Addict Biol; 2005 Jun 01; 10(2):187-95. PubMed ID: 16191672
    [Abstract] [Full Text] [Related]

  • 13. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
    Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H.
    J Neurol Neurosurg Psychiatry; 2000 Jun 01; 68(6):719-25. PubMed ID: 10811694
    [Abstract] [Full Text] [Related]

  • 14. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B.
    Arch Gen Psychiatry; 2007 Jun 01; 64(6):728-36. PubMed ID: 17548754
    [Abstract] [Full Text] [Related]

  • 15. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul 01; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 16. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
    Golding JF, Groome DH, Rycroft N, Denton Z.
    Am J Drug Alcohol Abuse; 2007 Jul 01; 33(2):301-7. PubMed ID: 17497553
    [Abstract] [Full Text] [Related]

  • 17. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug 01; 27(5):819-27. PubMed ID: 12921915
    [Abstract] [Full Text] [Related]

  • 18. Evidence of increased activation underlying cognitive control in ecstasy and cannabis users.
    Roberts GM, Garavan H.
    Neuroimage; 2010 Aug 15; 52(2):429-35. PubMed ID: 20417713
    [Abstract] [Full Text] [Related]

  • 19. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May 15; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 20. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC, Sands HR, Jones L, Clow A, Evans P, Downey LA, Stalder T.
    Eur Neuropsychopharmacol; 2014 Mar 15; 24(3):369-74. PubMed ID: 24333019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.